CD8A and cancer: However, cancer cells acquire the ability to escape from the antitumor immune response, and the dysregulated relationship between antagonistic effectors (i.e., CD8+ cytotoxic T-cells) and regulatory immune cells (i.e., Tregs) leads to a TME that can promote cancer development [11].